Family history assessment: Strategies for prevention of cardiovascular disease

American Journal of Preventive Medicine

Volumn 24, Issue 2, 2003, Pages 136-142

  Hunt, Steven C ^a   Gwinn, Marta ^b   Adams, Ted D ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

BLOOD PRESSURE; CARDIOVASCULAR DISEASE; COST EFFECTIVENESS ANALYSIS; FAMILY HISTORY; GENE; HEALTH PROMOTION; HIGH RISK POPULATION; HUMAN; PREVALENCE; PROPHYLAXIS; PUBLIC HEALTH; REVIEW; RISK FACTOR; SCREENING;

EID: 12244262220     PISSN: 07493797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0749-3797(02)00586-X     Document Type: Review

References (55)

1. Prevention of coronary heart disease. 1982;World Health Organization, Geneva.
2. Oliver M.F. Should we not forget about mass control of coronary risk factors? Lancet. 2:1983;37-38.
3. Kottke T.E., Puska P., Salonen J.T., Tuomilehto J., Nissinen A. Projected effects of high-risk versus population-based prevention strategies in coronary heart disease. Am J Epidemiol. 121:1985;697-704.
4. Kannel W.B. Prevalence, incidence, and mortality of coronary heart disease. Fuster V., Ross R., Topol E.J. Atherosclerosis and coronary artery disease. 1996;13-21 Lippincott-Raven Publishers, Philadelphia.
5. Burke G.L., Sprafka J.M., Folsom A.R., Luepker R.V., Norsted S.W., Blackburn H. Trends in CHD mortality, morbidity and risk factor levels from 1960 to 1986 the Minnesota Heart Survey . Int J Epidemiol. 18:(suppl):1989;73-81.
6. Rosamond W.D., Folsom A.R., Chambless L.E., Wang C.H. Coronary heart disease trends in four United States communities the Atherosclerosis Risk in Communities (ARIC) Study 1987-1996 . Int J Epidemiol. 30:(suppl 1):2001;17-22.
7. Gillum R.F., Sempos C.T. The end of the long-term decline in stroke mortality in the United States? Stroke. 28:1997;1527-1529.
8. Wald N.J., Hackshaw A.K., Frost C.D. When can a risk factor be used as a worthwhile screening test? BMJ. 319:1999;1562-1565.
9. Collins F.S., McKusick V.A. Implications of the Human Genome Project for medical science. JAMA. 285:2001;540-544.
10. Holtzman N.A., Marteau T.M. Will genetics revolutionize medicine? N Engl J Med. 343:2000;141-144.
11. Williams R.R., Hasstedt S.J., Hunt S.C., et al. Genetic traits related to hypertension and electrolyte metabolism. Hypertension. 17:(suppl 1):1991;69-73.
12. Hunt S.C., Hasstedt S.J., Kuida H., Stults B.M., Hopkins P.H., Williams R.R. Genetic heritability and common environmental components of resting and stressed blood pressures, lipids, and body mass index in Utah pedigrees and twins. Am J Epidemiol. 129:1989;625-638.
13. Hunt S.C., Williams R.R., Barlow G.K. A comparison of positive family history definitions for defining risk of future disease. J Chron Dis. 39:1986;809-821.
14. Williams R.R., Hunt S.C., Schumacher M.C., et al. Genes, hypertension and coronary heart disease evidence for shared metabolic pathophysiology . Smith U., Bruun N.E., Hedner T., Hokfelt B. Hypertension - an insulin-resistant disorder. Genetic factors and cellular mechanisms. 1991;89-101 Elsevier, Amsterdam.
15. Scheuner M.T., Wang S.J., Raffel L.J., Larabell S.K., Rotter J.I. Family history a comprehensive genetic risk assessment method for the chronic conditions of adulthood . Am J Med Genet. 71:1997;315-324.
16. Williams R.R., Hunt S.C., Heiss G., et al. Usefulness of cardiovascular family history data for population-based preventive medicine and medical research (the Health Family Tree Study and the NHLBI Family Heart Study). Am J Cardiol. 87:2001;129-135.
17. Pearson T.A., Blair S.N., Daniels S.R., et al. AHA Guidelines for primary prevention of cardiovascular disease and stroke 2002 update: consensus panel guide to comprehensive risk reduction for adult patients without coronary or other atherosclerotic vascular diseases . Circulation. 106:2002;388-391.
18. Shaper A.G., Pocock S.J., Phillips A.N., Walker M. Identifying men at high risk of heart attacks strategy for use in general practice . BMJ. 293:1986;474-479.
19. Hopkins P.N., Williams R.R., Kuida H., et al. Family history as an independent risk factor for incident coronary artery disease in a high-risk cohort in Utah. Am J Cardiol. 62:1988;703-707.
20. Sorensen T.I., Nielsen G.G., Andersen P.K., Teasdale T.W. Genetic and environmental influences on premature death in adult adoptees. N Engl J Med. 318:1988;727-732.
21. Myers R.H., Kiely D.K., Cupples L.A., Kannel W.B. Parental history is an independent risk factor for coronary artery disease the Framingham Study . Am Heart J. 120:1990;963-969.
22. Roncaglioni M.C., Santoro L., D'Avanzo B., et al. Role of family history in patients with myocardial infarction. An Italian case-control study. GISSI-EFRIM Investigators. Circulation. 85:1992;2065-2072.
23. Grech E.D., Ramsdale D.R., Bray C.L., Faragher E.B. Family history as an independent risk factor of coronary artery disease. Eur Heart J. 13:1992;1311-1315.
24. Castro-Beiras A., Muniz J., Fernandez-Fuertes I., et al. Family history as an independent risk factor for ischaemic heart disease in a low incidence area (Galicia, Spain). Eur Heart J. 14:1993;1445-1450.
25. Marenberg M.E., Risch N., Berkman L.F., Floderus B., de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med. 330:1994;1041-1046.
26. Eaton C.B., Bostom A.G., Yanek L., et al. Family history and premature coronary heart disease. J Am Board Fam Pract. 9:1996;312-318.
27. Boer J.M., Feskens E.J., Verschuren W.M., Seidell J.C., Kromhout D. The joint impact of family history of myocardial infarction and other risk factors on 12-year coronary heart disease mortality. Epidemiology. 10:1999;767-770.
28. Friedlander Y., Arbogast P., Schwartz S.M., et al. Family history as a risk factor for early onset myocardial infarction in young women. Atherosclerosis. 156:2001;201-207.
29. Stamler J., Wentworth D., Neaton J.D. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA. 256:1986;2823-2828.
30. Stamler J., Stamler R., Neaton J.D., et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy findings for 5 large cohorts of young adult and middle-aged men and women . JAMA. 282:1999;2012-2018.
31. Magnus P., Beaglehole R. The real contribution of the major risk factors to the coronary epidemics time to end the "only-50%" myth . Arch Intern Med. 161:2001;2657-2660.
32. Connor W.E., Connor S.L. Importance of diet in the treatment of familial hypercholesterolemia. Am J Cardiol. 72:1993;42-53.
33. Williams R.R., Hamilton-Craig I., Costner G.M., et al. MED-PED an integrated genetic strategy for preventing early deaths . Berg K., Boulyjenkov V., Christen Y. Genetic approaches to noncommunicable diseases. 1996;35-45 Springer-Verlag, Heidelberg.
34. Williams R.R., Hunt S.C., Schumacher M.C., et al. Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics. Am J Cardiol. 72:1993;171-176.
35. Austin M.A., Zimmern R.L., Humphries S.E. High "population attributable fraction" for coronary heart disease mortality among relatives in monogenic familial hypercholesterolemia. Genet Med. 4:2002;275-278.
36. Gerdes L.U., Gerdes C., Kervinen K., et al. The apolipoprotein epsilon4 allele determines prognosis and the effect on prognosis of simvastatin in survivors of myocardial infarction a substudy of the Scandinavian simvastatin survival study . Circulation. 101:2000;1366-1371.
37. Pedro-Botet J., Schaefer E.J., Bakker-Arkema R.G., et al. Apolipoprotein E genotype affects plasma lipid response to atorvastatin in a gender specific manner. Atherosclerosis. 158:2001;183-193.
38. Perez-Martinez P., Gomez P., Paz E., et al. Interaction between smoking and the Sstl polymorphism of the apo C-III gene determines plasma lipid response to diet. Nutr Metab Cardiovasc Dis. 11:2001;237-243.
39. Ordovas J.M., Galluzzi J.R. Genetic predictors of plasma lipid response to diet intervention. Curr Atheroscler Rep. 1:1999;196-203.
40. Hunt S.C., Cook N.R., Oberman A., et al. Angiotensinogen genotype, sodium reduction, weight loss, and prevention of hypertension trials of hypertension prevention, phase II . Hypertension. 32:1998;393-401.
41. Hunt S.C., Geleijnse J.M., Wu L.L., Witteman J.C.M., Williams R.R., Grobbee D.E. Enhanced blood pressure response to mild sodium reduction in subjects with the 235T variant of the angiotensinogen gene. Am J Hypertens. 12:1999;460-466.
42. Svetkey L.P., Moore T.J., Simons-Morton D.G., et al. Angiotensinogen genotype and blood pressure response in the Dietary Approaches to Stop Hypertension (DASH) study. J Hypertens. 19:2001;1949-1956.
43. Hopkins P.N., Williams R.R., Hunt S.C. Magnified risks from cigarette smoking for coronary prone families in Utah. West J Med. 141:1984;196-202.
44. The sixth report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure. Arch Intern Med. 157:1997;2413-2446.
45. Williams R.R., Hunt S.C., Barlow G.K., et al. Health family trees a tool for finding and helping young members of coronary and cancer prone pedigrees in Texas and Utah . Am J Public Health. 78:1988;1283-1286.
46. Multiple risk factor intervention trial. Risk factor changes and mortality results. Multiple Risk Factor Intervention Trial Research Group. JAMA. 248:1982;1465-1477.
47. Kottke T.E., Daida H. Evaluating the effectiveness of dyslipidemia control strategies. Atherosclerosis. 108:(suppl):1994;127-135.
48. Kottke T.E., Gatewood L.C., Park H.A. Using serum cholesterol to identify high risk and stimulate behavior change will it work? Ann Med. 21:1989;181-187.
49. Goldman L., Weinstein M.C., Goldman P.A., Williams L.W. Cost-effectiveness of HMG-CoA reductase inhibition for primary and secondary prevention of coronary heart disease. JAMA. 265:1991;1145-1151.
50. Strychar I.M., Champagne F., Ghadirian P., Bonin A., Jenicek M., Lasater T.M. Impact of receiving blood cholesterol test results on dietary change. Am J Prev Med. 14:1998;103-110.
51. Rimer B.K., Schildkraut J.M., Lerman C., Lin T.H., Audrain J. Participation in a women's breast cancer risk counseling trial. Who participates? Who declines? High Risk Breast Cancer Consortium. Cancer. 77:1996;2348-2355.
52. Polley B.A., Jakicic J.M., Venditti E.M., Barr S., Wing R.R. The effects of health beliefs on weight loss in individuals at high risk for NIDDM. Diabetes Care. 20:1997;1533-1538.
53. Emery J., Rose P. Expanding the role of the family history in primary care. Br J Gen Pract. 49:1999;260-261.
54. Swanson J.R., Pearson T.A. Screening family members at high risk for coronary disease. Why isn't it done? Am J Prev Med. 20:2001;50-55.
55. Westman J., Hampel H., Bradley T. Efficacy of a touchscreen computer based family cancer history questionnaire and subsequent cancer risk assessment. J Med Genet. 37:2000;354-360.